Low Blood Pressure Clinical Trials

Find Low Blood Pressure Clinical Trials Near You

The Impact of Propofol and Ketamine on Cardiovascular Collapse During Induction for Endotracheal Intubation in Critically Ill Patients: A Prospective Observational Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

This prospective observational study evaluates the impact of propofol and ketamine on the risk of cardiovascular collapse during induction for endotracheal intubation in critically ill patients. Induction agents play a crucial role in managing hemodynamic stability, particularly in this vulnerable population. Propofol, known for its vasodilatory and myocardial depressant effects, has been associated with significant hypotension during induction. Conversely, ketamine, with its sympathomimetic properties, is often considered a safer alternative for hemodynamic stability. In addition to comparing the incidence of cardiovascular collapse-defined as severe hypotension or cardiac arrest-this study examines the relationship between these induction agents and shock indices, including systolic shock index, diastolic shock index, age-adjusted shock index, and modified shock index. These parameters will provide a more detailed understanding of the hemodynamic effects of each agent and their clinical implications. The findings aim to guide induction agent selection to optimize outcomes in critically ill patients.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• Patients aged over 18 years

• Patients admitted to the intensive care unit (ICU) who undergo endotracheal intubation during their ICU stay will be included.

Locations
Other Locations
Turkey
Kocaeli City Hospital
RECRUITING
Köseköy
Contact Information
Primary
Ömer Emgin, MD
omermgin@yahoo.com
+90 262 225 27 00
Time Frame
Start Date: 2024-07-15
Estimated Completion Date: 2025-11-01
Participants
Target number of participants: 128
Treatments
Cardiovascular collapse
- At least one documented episode of SpO₂ \< 80%, ensuring accuracy of measurement.~* At least one episode of systolic arterial blood pressure (SAB) \< 65 mmHg.~* SAB \< 90 mmHg sustained for a duration of 30 minutes.~* Initiation of norepinephrine therapy.~* Escalation of pre-existing norepinephrine infusion dose.~* Administration of \>15 mL/kg crystalloid fluids to achieve SAB \> 90 mmHg.~* Occurrence of cardiac arrest. The occurrence of any of the above-mentioned events within the first 30 minutes following the initiation of the intervention will be considered as cardiovascular collapse.
No Cardiovascular collapse
Related Therapeutic Areas
Sponsors
Leads: Kocaeli City Hospital

This content was sourced from clinicaltrials.gov

Similar Clinical Trials